Drug intelligence / Profile preview

Korovit

Development stage
Unknown
Lead developer
Robugen
Modality
Small Molecules
Administration
Oral
01

Overview

Korovit is an oral cardiovascular medication developed and manufactured by Robugen, primarily indicated for the treatment of functional circulatory disorders and hypotension. It is a combination product containing D-camphor and a thick extract of hawthorn berries (Crataegus). Camphor acts as a circulatory stimulant by targeting the vasomotor centers in the central nervous system, leading to increased peripheral vascular tone and blood pressure stabilization. Hawthorn extract provides cardiotonic support, traditionally used to enhance cardiac efficiency and improve blood flow through positive inotropic effects. The drug is approved in Germany as a traditional herbal medicine for supporting cardiovascular function, particularly in cases of orthostatic dysregulation or age-related circulatory instability.

Brand names
KorovitKOROVIT Kreislauf-Kapseln
Other names
KOROVIT Kreislauf-Kapseln
02

Targets

TRPV3 (Transient receptor potential vanilloid subtype 3)

Beyond the preview

Go deeper on Korovit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Korovit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call